TrialFrontiers in endocrinology2022

Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.

Jiaqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.